Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Feb 26;30(2):69–74. doi: 10.1002/clc.19

Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)

Timothy R Wessel 1, Christopher B Arant 1, Susan P McGorray 1, Barry L Sharaf 2, Steven E Reis 3, Richard A Kerensky 1, Gregory O von Mering 1, Karen M Smith 1, Daniel F Pauly 1, Eileen M Handberg 1, Sunil Mankad 4, Marian B Olson 3, B Delia Johnson 3, C Noel Bairey Merz 5, George Sopko 6, Carl J Pepine 1,
PMCID: PMC6653045  PMID: 17326061

Abstract

Background

Altered coronary reactivity is frequent in women with findings of myocardial ischemia without significant obstructive disease. This suggests a defect in coronary microvascular function. The adenosine‐related component of this altered reactivity has been described in male and mixed gender populations, while the factors influencing this component of coronary reactivity in symptomatic women have received limited attention. Accordingly, the relationship between adenosine‐related microvascular coronary reactivity and risk factors in symptomatic women evaluated for suspected ischemia remains uncertain.

Hypothesis

Abnormal coronary microvascular reactivity to adenosine is predicted by atherosclerosis risk factors in women.

Methods

As part of the NHLBI‐sponsored Women's Ischemia Syndrome Evaluation (WISE), we investigated the relationship between risk factors and coronary microvascular reactivity as flow velocity reserve to intracoronary adenosine (CFVRAdo) in 210 women referred for angiography to evaluate suspected ischemia.

Results

Univariate analyses identified associations between CFVRAdo and multiple risk conditions; however, after adjusting for age, none remained significant. The best multivariable model using combinations of risk conditions to predict CFVRAdo yielded an R2 of only 0.18.

Conclusions

Among women with suspected ischemia, risk factors account for <20% of observed variability in CFVRAdo. Therefore, other as yet unidentified factors must primarily account for coronary microvascular reactivity to adenosine. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: women, risk factors, microcirculation, adenosine

Full Text

The Full Text of this article is available as a PDF (121.9 KB).

REFERENCES

  • 1. Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, et al.: Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study. Am Heart J 2001; 141: 735–741. [DOI] [PubMed] [Google Scholar]
  • 2. Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, et al.: The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institues of Health‐National Heart, Lung, and Blood Institute‐sponsored Women's Ischemia Syndrome Evaluation. Circulation 2006; 114: 894–904. [DOI] [PubMed] [Google Scholar]
  • 3. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, et al.: Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653–658. [DOI] [PubMed] [Google Scholar]
  • 4. Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre J, et al.: Positron emission tomography‐measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 2005; 45: 1505–1512. [DOI] [PubMed] [Google Scholar]
  • 5. von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, et al.: Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 722–725. [DOI] [PubMed] [Google Scholar]
  • 6. Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, et al.: Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 2004; 110: 3604–3609. [DOI] [PubMed] [Google Scholar]
  • 7. Moreau P, d'Uscio LV, Luscher TF: Structure and reactivity of small arteries in aging. Cardiovasc Res 1998; 37: 247–253. [DOI] [PubMed] [Google Scholar]
  • 8. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, et al.: Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003; 21: 625–631. [DOI] [PubMed] [Google Scholar]
  • 9. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, et al.: Impairment of coronary vascular reserve and ACh‐induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993; 42: 1017–1025. [DOI] [PubMed] [Google Scholar]
  • 10. Kaufmann PA, Gnecchi‐Ruscone T, Schafers KP, Luscher TF, Camici PG: Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000; 36: 103–109. [DOI] [PubMed] [Google Scholar]
  • 11. Dagres N, Saller B, Haude M, Husing J, von Birgelen C, et al.: Insulin sensitivity and coronary vasoreactivity: Insulin sensitivity relates to adenosine‐stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf) 2004; 61: 724–731. [DOI] [PubMed] [Google Scholar]
  • 12. Jesmin S, Sakuma I, Hattori Y, Kitabatake A: In vivo estrogen manipulations on coronary capillary network and angiogenic molecule expression in middle‐aged female rats. Arterioscler Thromb Vasc Biol 2002; 22: 1591–1597. [DOI] [PubMed] [Google Scholar]
  • 13. Lamping KG, Christensen LP, Tomanek RJ: Estrogen therapy induces collateral and microvascular remodeling. Am J Physiol Heart Circ Physiol 2003; 285: H2039–H2044. [DOI] [PubMed] [Google Scholar]
  • 14. Opherk D, Schuler G, Wetterauer K, Manthey J, Schwarz F, et al.: Four‐year follow‐up study in patients with angina pectoris and normal coronary arteriograms (“syndrome X”). Circulation 1989; 80: 1610–1616. [DOI] [PubMed] [Google Scholar]
  • 15. Heaps CL, Bowles DK: Gender‐specific K(+)‐channel contribution to adenosine‐induced relaxation in coronary arterioles. J Appl Physiol 2002; 92: 550–558. [DOI] [PubMed] [Google Scholar]
  • 16. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, et al.: Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346: 1948–1953. [DOI] [PubMed] [Google Scholar]
  • 17. Bottcher M, Botker HE, Sonne H, Nielsen TT, Czernin J: Endothelium‐dependent and ‐independent perfusion reserve and the effect of L‐arginine on myocardial perfusion in patients with syndrome X. Circulation 1999; 99: 1795–1801. [DOI] [PubMed] [Google Scholar]
  • 18. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, et al.: The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33: 1453–1461. [DOI] [PubMed] [Google Scholar]
  • 19. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, et al.: Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. J Am Med Assoc 2002; 287: 1153–1159. [DOI] [PubMed] [Google Scholar]
  • 20. Rifai N, Joubran R, Yu H, Asmi M, Jouma M: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 1999; 45: 1967–1973. [PubMed] [Google Scholar]
  • 21. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, et al.: Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI‐sponsored Women's Ischemia Syndrome Evaluation (WISE) Study Angiographic Core Laboratory). Am J Cardiol 2001; 87: 937–941. [DOI] [PubMed] [Google Scholar]
  • 22. Hasdai D, Holmes DR Jr, Higano ST, Burnett JC Jr, Lerman A: Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc 1998; 73: 1133–1140. [DOI] [PubMed] [Google Scholar]
  • 23. Wessel TR, Arant CB, Olson MB, Johnson BD, Reis SE, et al.: Relationship of physical fitness vs. body mass index with coronary artery disease and cardiovascular events in women. J Am Med Assoc 2004; 292: 1179–1187. [DOI] [PubMed] [Google Scholar]
  • 24. Reis SE, Holubkov R, Lee JS, Sharaf B, Reichek N, et al.: Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999; 33: 1469–1475. [DOI] [PubMed] [Google Scholar]
  • 25. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, et al.: Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH‐NHLBI‐sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006; 27: 1408–1415. [DOI] [PubMed] [Google Scholar]
  • 26. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, et al.: Impaired vascular reactivity in insulin‐dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996; 28: 573–579. [DOI] [PubMed] [Google Scholar]
  • 27. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, et al.: Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 726–732. [DOI] [PubMed] [Google Scholar]
  • 28. Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, et al.: Adequacy of intracoronary versus intravenous adenosine‐induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 2000; 140: 651–657. [DOI] [PubMed] [Google Scholar]
  • 29. Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, et al.: Coronary pressure measurement after stenting predicts adverse events at follow‐up: A multicenter registry. Circulation 2002; 105: 2950–2954. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES